Table 2 Frequency of main phenotypic findings in this study compared to previously published cases.

From: Broadening the phenotypic and molecular spectrum of FINCA syndrome: Biallelic NHLRC2 variants in 15 novel individuals

Phenotype

HPO

this cohort (n = 15)

literature (n = 13)

total (n = 28)

Growth parameters/development

Short stature (+ growth retardation)

HP:0004322

7/15

2/6

9/21

Decreased body weight (+ poor weight gain)

HP:0004325

9/15

8/13

17/28

(borderline) microcephaly (< = − 2 SD at last clinical examination)

HP:0040196

4/10

0/4

4/14

Neurological findings

Global developmental delay, intellectual disability

HP:0001263, HP:0001249

15/15

13/13

28/28

Speech or motor regression

HP:0002376

6/10

1/5

7/15

Behavioural abnormalties (+ irritability)

HP:0000708

7/15

11/12

18/27

Brain abnormalties (dilated lateral ventricles, this corpus callosum, brain atrophy)

HP:0012443

5/11

7/9

12/20

Gait disturbance (ataxic, unbalanced)

HP:0002066

5/9

3/5

8/14

Movement disorder (dystonia, spasticity)

HP:0001332

4/14

9/11

13/25

Axial hypotonia

HP:0008936

12/15

11/12

23/27

Seizures, EEG abnormalties

HP:0001250, HP:0002353

11/15

9/12

20/27

Pulmonary findings

Respiratory distress in infancy

HP:0002098

2/15

9/13

11/28

Recurrent respiratory infections

HP:0002205

2/15

11/12

13/27

Interstitial changes on chest-CT

HP:0006530

0/1

7/9

7/10

Other symptoms

Hepatomegaly

HP:0002240

1/15

4/12

5/27

Diarrhea

HP:0002014

2/15

8/11

10/26

Cardiovascular abnormality

HP:0001626

2/15

3/13

5/28

Ophthalmologic findings (strabismus)

HP:0000486

3/14

5/13

8/27

Hematological system (anemia)

HP:0001903

2/15

8/13

10/28

Angiomatosis-like cerebral lesions (post-mortem examination)

HP:0009145

0/0

3/3

3/3